Small Interfering RNA Targeted to ASPP2 Promotes Progression of Experimental Proliferative Vitreoretinopathy

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Stages</td><td class="align_center">Characteristics</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">0</td><td class="align_center">No proliferative response</td></tr><tr><td class="align_left">1</td><td class="align_center">Intravitreal proliferation</td></tr><tr><td class="align_left">2</td><td class="align_center">Preretinal membrane formation with retinal folds</td></tr><tr><td class="align_left">3</td><td class="align_center">White dense membrane covering the retina with retinal folds, localized retinal detachments, with or without localized posterior capsular cataract</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Criteria for stages of proliferative vitreoretinopathy (adapted from [<a href="/journals/mi/2016/7920631/#B31">30</a>]). 

Mediators of Inflammation

tab2

Table 2

Table 2: Small Interfering RNA Targeted to ASPP2 Promotes Progression of Experimental Proliferative Vitreoretinopathy 